NPPA Turns to Patent Office for Clarity on Drug Price Exemptions, Defers Intas, Biological E's Applications Farhat Nasim20 Dec 2024 6:11 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has sought expertise from the Indian Patent Office to assist in making decisions...
Low dose clozapine effective in Indians with drug induced tardive dyskinesia and dystonia, finds study Jacinthlyn Sylvia8 Nov 2024 9:30 PM ISTA new study published in the Asian Journal of Psychiatry showed that people of Indian heritage require lower effective dosages of clozapine for drug...
Evenamide effects significant improvement of symptoms in resistant schizophrenia Dr. Kamal Kant Kohli29 Oct 2023 9:30 PM ISTInvestigational drug evenamide is an effective adjunct treatment for resistant schizophrenia, according to a pree release by manufacturer. It...
Noninvasive finger sweat testing may help monitor drug adherence among antipsychotic patients Dr. Kamal Kant Kohli19 Sept 2023 8:00 PM ISTUK: Scientists have now discovered a way to test the levels of common antipsychotic drugs in the sweat from patients fingerprints, offering a quicker,...
Clozapine, but not olanzapine or quetiapine, linked with higher perimyocarditis and HF risk Dr. Kamal Kant Kohli2 Sept 2023 9:45 AM ISTA recent population-based study published in Psychiatry Research by Eric Clapham and colleagues has studied concerns about associations between the...
Clozapine use in schizophrenia linked to notably less insomnia compared to other antipsychotics Dr. Kamal Kant Kohli28 April 2023 3:00 AM ISTUSA: Patients with schizophrenia treated with clozapine may experience significantly less insomnia than those treated with other antipsychotics, a new...
Long-term clozapine use associated with increased odds of haematological malignancies: Lancet Dr. Shravani Dali28 March 2022 5:15 AM ISTLong-term clozapine use is associated with increased odds of haematological malignancies, according to a recent study published in The Lancet...
Intas pharma gets CDSCO panel nod to manufacture, market schizophrenia drug Clozapine Susmita Roy21 Feb 2022 5:00 PM ISTNew Delhi: Pharmaceutical major Intas Pharmaceuticals has got a green signal from the Subject Expert Committee (SEC) functional under the Central...
Clozapine therapy, what to do when an "absolute indication" is coupled with a strong "contraindication"? Dr. Shivi Kataria17 Feb 2021 8:30 AM ISTAn interesting case study published in Hindawi journal by Neill et al. showcases a rare case of late-onset neutropenia (after 14 years) in a clozapine...
Clozapine effective option for violent schizophrenia patients with conduct disorder Dr. Nandita Mohan3 Feb 2021 10:15 PM ISTIt has been recently observed by the researchers from the Department of Psychiatry, Nathan Kline Institute for Psychiatric Research, Orangeburg, N.Y....
FDA updates warning against clozapine-induced constipation Dr. Kamal Kant Kohli3 Feb 2020 4:26 PM ISTUSA: FDA medication like clozapine may induce constipation which is a common side effect of the drug. There may be an increased risk of serious bowel...
